Meta-Analysis of Oral Anticoagulants and Adverse Outcomes in Atrial Fibrillation Patients After Intracranial Hemorrhage

BACKGROUND: Intracranial hemorrhage (ICH) is excluded in most anticoagulation randomized clinical trials (RCTs), so oral anticoagulant (OAC) therapy is still the conventional treatment for patients with atrial fibrillation (AF) after ICH. Therefore, we conducted a meta-analysis to determine the effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xin, Guo, Siyu, Xu, Zhicheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334654/
https://www.ncbi.nlm.nih.gov/pubmed/35911529
http://dx.doi.org/10.3389/fcvm.2022.961000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334654/
https://www.ncbi.nlm.nih.gov/pubmed/35911529
http://dx.doi.org/10.3389/fcvm.2022.961000

Ejemplares similares